:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Fhealthify-logo.png){kind=logo}
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FNordic-logo.png){kind=logo}
SV Health Investors Announces the Appointment of Megan MacDonagh
SV Health Investors welcomes six new Venture Partners to the Biotech team
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FSchweiger-logo-light-blue.png){kind=logo}
Clarify Medical Now Approved as a MultiPlan Participating Provider
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCentauri-logo.png){kind=logo}
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2FSV-website-news.jpg)
British Patient Capital commits $65m to SV Health Investors, to invest in life-changing biotechnology companies
SV Health Investors hits $265m final close for first dedicated biotech fundraiseRead More
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Fevidation-wordmark-black-cmyk.png)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Fkate-binghama-banner.jpg)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FQuralisRectangle-logo.png)
28 September 2020Portfolio NewsQurAlis named as one of Fierce Biotech's 2020 Fierce 15
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCerevance.jpg)
22 July 2020Portfolio NewsExcellent news today from our portfolio company @Cerevance on the expansion of its Series B financing round, adding a further $20 million to the $45 million announced in April.
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FQuralisRectangle-logo.png)
1 July 2020Portfolio NewsQurAlis Announces Agreement to Strengthen ALS Pipeline
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FAstronauTX-Logo_200414_111145.png)
2 June 2020Portfolio NewsAstronauTx Announces an Alliance With Concept Life Sciences to Accelerate the Identification of Novel Therapies For Alzheimer's Disease
:no_upscale()/svhi.fra1.digitaloceanspaces.com%2FQurAlis-logo.png)
13 May 2020Portfolio NewsQurAlis raises $42 Million Series A Financing to Develop New Therapies for Amyotrophic Lateral Sclerosis (ALS)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FNitrome_logo_2020.png)
23 April 2020Portfolio NewsNitrome Biosciences Raises $38M Series A Financing to Advance Therapeutics Targeting a Novel Group of Enzymes involved in Age-related Diseases
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FEvelo.png)
15 April 2020Portfolio NewsEvelo Biosciences Appoints Neil Graham, M.D., M.B.B.S., M.P.H., as Chief Development Officer - an industry veteran who brings deep experience in drug development from leadership roles at Regeneron and Vertex- 14 April 2020Portfolio NewsCerevance Closes $45 Million Series B Financing - proceeds to fund a diverse pipeline of therapeutics acting on novel targets for brain diseases
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FAlector-Logo.png)
24 March 2020Portfolio NewsAlector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors
:no_upscale()/svhi.fra1.digitaloceanspaces.com%2FDDF-logo.png)
9 September 2019SV NewsDDF notes the appointment of Christian Jung, PhD as Partner- 12 August 2019Portfolio NewsDDF notes AstronauTx secures £6.5 million Financing with Investment from DDF
- 23 October 2018SV NewsDDF launches new research accelerator partnership with the UK DRI